MD Anderson Research Highlights For September 28, 2022
September 29, 2022
September 29, 2022
HOUSTON, Texas, Sept. 29 (TNSjou) -- The University of Texas's MD Anderson Cancer Center issued the following news release:
* * *
Featuring cancer survivorship studies, new combination therapies for breast cancer and leukemia, and an analysis of RAS mutations in AML
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Ande . . .
* * *
Featuring cancer survivorship studies, new combination therapies for breast cancer and leukemia, and an analysis of RAS mutations in AML
* * *
The University of Texas MD Anderson Cancer Center's Research Highlights provides a glimpse into recent basic, translational and clinical cancer research from MD Ande . . .